Regulation ‘must keep pace’ with AI revolution: RACGP While AI may help reduce the administrative burden for GPs significantly, a college submission has said regulatory concerns need addressing.
TGA flags focus on illegal vapes Unlawful nicotine vaping products and medicinal cannabis advertising are priority areas for the medicine regulator for the next year.
GlucaGen Hypokit in short supply until October Another diabetes medication is now facing supply issues, adding to worldwide shortages of semaglutide and dulaglutide.
Pharmacy green light for insulin swap due to shortage Pharmacists have been given permission to substitute a type of insulin pen due to ongoing supply issues that will likely last well into 2024.
New advice for ‘unprecedented’ antibiotics shortage With ongoing supply issues, Therapeutic Guidelines has released a guide for prescribers on alternatives in the absence of first-line therapies.
Telehealth provider defies TGA semaglutide request Eucalyptus is reportedly offering patients access to the type 2 diabetes-indicated drug for weight loss purposes, despite ongoing supply issues.
Psychedelic prescribing to begin for PTSD and depression Experts are split on whether Australia is prepared for psychedelic-assisted therapy, but GPs need to be ready to answer questions and refer patients.
GP aged care standards launched for the first time New college standards set out ‘minimum requirements’ to provide high-quality care in residential aged care homes.
‘A very challenging space’: Opioid deprescribing guide released Work for guidelines was led by researchers at the University of Sydney and includes 11 recommendations with general practice in mind.
TGA’s vaping crackdown a sign of things to come The medicines regulator issued infringement notices to four entities this week, totalling almost $600,000.